ANI Pharma gets US FDA nod for Nitrofurantoin Oral Suspension USP
ANI’s Nitrofurantoin Oral Suspension is the generic version of RLD Furadantin Oral Suspension
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ANDA approval
Generic drug development: The way forward
Anantha Keerthi, Partner, Vector Consulting Group, points out that pharma companies need to either launch many new speciality…
Zydus gets USFDA approval for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25…
Carbidopa and Levodopa are used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Zydus gets USFDA nod for Acetazolamide Tablets USP, 125 mg and 250 mg
Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision.…
Glenmark gets USFDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg
Glenmark’s current portfolio consists of 182 products authorised for distribution in the US marketplace
Unichem gets USFDA approval for ranolazine ER tablets, 500 mg and 1000 mg
Ranolazine ER tablets are indicated for the treatment of chronic angina
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 mL pharmacy bulk vial
It is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric…
Zydus gets final US FDA approval for Vigabatrin for Oral Solution USP, 500 mg
Vigabatrin for oral solution is indicated for the treatment of refractory complex partial seizures as adjunctive therapy in…
Alembic Pharma gets USFDA nod for Docetaxel Injection USP
Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric…
Glenmark gets second tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
Glenmark’s first tentative approval letter for Saxagliptin Tablets, 2.5 mg and 5 mg was received on June 12, 2017